These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31378636)

  • 21. Chronic proton pump inhibitor therapy and the risk of colorectal cancer.
    Yang YX; Hennessy S; Propert K; Hwang WT; Sedarat A; Lewis JD
    Gastroenterology; 2007 Sep; 133(3):748-54. PubMed ID: 17678926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial.
    Bosch J; Eikelboom JW; Connolly SJ; Bruns NC; Lanius V; Yuan F; Misselwitz F; Chen E; Diaz R; Alings M; Lonn EM; Widimsky P; Hori M; Avezum A; Piegas LS; Bhatt DL; Branch KRH; Probstfield JL; Liang Y; Liu L; Zhu J; Maggioni AP; Lopez-Jaramillo P; O'Donnell M; Fox KAA; Kakkar A; Parkhomenko AN; Ertl G; Störk S; Keltai K; Keltai M; Ryden L; Dagenais GR; Pogosova N; Dans AL; Lanas F; Commerford PJ; Torp-Pedersen C; Guzik TJ; Verhamme PB; Vinereanu D; Kim JH; Ha JW; Tonkin AM; Varigos JD; Lewis BS; Felix C; Yusoff K; Steg PG; Aboyans V; Metsarinne KP; Anand SS; Hart RG; Lamy A; Moayyedi P; Leong DP; Sharma M; Yusuf S
    Can J Cardiol; 2017 Aug; 33(8):1027-1035. PubMed ID: 28754388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.
    Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC
    Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Guidelines for the appropriate use of non-steroidal anti-inflammatory drugs, cyclo-oxygenase-2-specific inhibitors and proton pump inhibitors in patients requiring chronic anti-inflammatory therapy.
    Dubois RW; Melmed GY; Henning JM; Laine L
    Aliment Pharmacol Ther; 2004 Jan; 19(2):197-208. PubMed ID: 14723611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low yield of endoscopy in patients with persistent dyspepsia taking proton pump inhibitors.
    Smith T; Verzola E; Mertz H
    Gastrointest Endosc; 2003 Jul; 58(1):9-13. PubMed ID: 12838213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-dose or standard-dose proton pump inhibitors for maintenance therapy of gastro-oesophageal reflux disease: a cost-effectiveness analysis.
    You JH; Lee AC; Wong SC; Chan FK
    Aliment Pharmacol Ther; 2003 Mar; 17(6):785-92. PubMed ID: 12641500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Helicobacter pylori infection and the prevention of peptic ulcer with proton pump inhibitors in elderly subjects taking low-dose aspirin.
    Pilotto A; Franceschi M; Longoa MG; Scarcelli C; Orsitto G; Perri FC; D'Ambrosio LP; Leandro G
    Dig Liver Dis; 2004 Oct; 36(10):666-70. PubMed ID: 15506665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and Safety of Proton Pump Inhibitors in the Long-Term Aspirin Users: A Meta-Analysis of Randomized Controlled Trials.
    Dahal K; Sharma SP; Kaur J; Anderson BJ; Singh G
    Am J Ther; 2017; 24(5):e559-e569. PubMed ID: 28763306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Editorial: proton pump inhibitor therapy and liver disease progression-more cause for concern?
    Macnaughtan J; Jalan R
    Aliment Pharmacol Ther; 2018 Jan; 47(2):304-305. PubMed ID: 29265457
    [No Abstract]   [Full Text] [Related]  

  • 30. Proton pump inhibitor therapy after
    Tan MC; Graham DY
    BMJ Evid Based Med; 2018 Jun; 23(3):111-112. PubMed ID: 29599181
    [No Abstract]   [Full Text] [Related]  

  • 31. Review article: alternative approaches to the long-term management of GERD.
    Fennerty MB
    Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():39-44. PubMed ID: 16303036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct oral anticoagulant use and subsequent start of proton pump inhibitors as proxy for gastric complaints.
    Zielinski GD; Teichert M; Klok FA; Rosendaal FR; Huisman MV; Cannegieter SC; Lijfering WM
    Pharmacoepidemiol Drug Saf; 2018 Dec; 27(12):1371-1378. PubMed ID: 30443944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Editorial: is proton pump inhibitor use associated with worse outcomes in patients with liver abscesses?
    Tabibian JH; Lindor KD
    Aliment Pharmacol Ther; 2018 Apr; 47(8):1226-1227. PubMed ID: 29574873
    [No Abstract]   [Full Text] [Related]  

  • 34. Cardioprotective effects and gastrointestinal risks of aspirin: maintaining the delicate balance.
    Kimmey MB
    Am J Med; 2004 Sep; 117 Suppl 5A():72S-78S. PubMed ID: 15478856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term use of proton pump inhibitors and vitamin B12 status in elderly individuals.
    den Elzen WP; Groeneveld Y; de Ruijter W; Souverijn JH; le Cessie S; Assendelft WJ; Gussekloo J
    Aliment Pharmacol Ther; 2008 Mar; 27(6):491-7. PubMed ID: 18194503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pantoprazole did not reduce risk for a composite of upper gastrointestinal events in stable arterial disease.
    Dayanand P; Borzak S
    Ann Intern Med; 2019 Oct; 171(8):JC45. PubMed ID: 31610558
    [No Abstract]   [Full Text] [Related]  

  • 37. [Proton pump inhibitors in gastro-oesophageal reflux disease: what is the further step?].
    Simon M; Zerbib F
    Presse Med; 2013; 42(7-8):1081-4. PubMed ID: 23079391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do proton pump inhibitors attenuate the effect of aspirin on platelet aggregation? A randomized crossover study.
    Adamopoulos AB; Sakizlis GN; Nasothimiou EG; Anastasopoulou I; Anastasakou E; Kotsi P; Karafoulidou A; Stergiou GS
    J Cardiovasc Pharmacol; 2009 Aug; 54(2):163-8. PubMed ID: 19568178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Refractory regurgitation responds to magnetic sphincter augmentation but not to increased proton pump inhibitor dose.
    DeVault KR
    Gastrointest Endosc; 2019 Jan; 89(1):23-24. PubMed ID: 30567683
    [No Abstract]   [Full Text] [Related]  

  • 40. Patterns of proton pump inhibitor use in clinical practice.
    Barrison AF; Jarboe LA; Weinberg BM; Nimmagadda K; Sullivan LM; Wolfe MM
    Am J Med; 2001 Oct; 111(6):469-73. PubMed ID: 11690573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.